Đang chuẩn bị liên kết để tải về tài liệu:
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: A retrospective cohort study

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Adherence to chronic obstructive pulmonary disease (COPD) maintenance medication is important for managing symptoms and exacerbation risk, and is associated with reduced mortality, hospitalizations, and costs. |

TÀI LIỆU LIÊN QUAN